Navigation Links
Shire Withdraws European Application for DAYTRANA(TM) (Methylphenidate Transdermal System)
Date:3/16/2009

DUBLIN, March 16 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announces that it has decided to withdraw the European Marketing Authorization Application (MAA) for DAYTRANA(TM) (methylphenidate transdermal system) for the treatment of Attention Deficit Hyperactivity Disorder (ADHD). A request from European regulators to conduct an additional clinical study on DAYTRANA in a European patient population combined with the recently announced planned acquisition of the worldwide rights (excluding the US, Canada and Barbados) to EQUASYM(R) IR and XL (methylphenidate hydrochloride) for the treatment of ADHD are the basis for this decision.

The decision to withdraw the MAA does not impact Shire's commitment to DAYTRANA in the U.S. where the product has been used as a pediatric treatment for ADHD since 2006.

EQUASYM IR and XL will provide Shire with an entry to the European ADHD market upon completion of the transaction, which subject to customary completion conditions, is anticipated in Q2 2009. EQUASYM XL is approved and currently marketed for the treatment of ADHD in children over 6 years of age, and is available in 10 countries outside of the US, Canada and Barbados including Denmark, Finland, Germany, Ireland, Netherlands, Norway, Sweden, UK, Mexico and South Korea. Shire will be working to progress a number of additional planned launches for EQUASYM XL in European and ROW markets.

EQUASYM will allow Shire to build on its status as the leader in the United States ADHD market with patients and customers in Europe, and establishes a solid bridge for Shire's other ADHD treatments, including VYVANSE(TM) (lisdexamfetamine dimesylate), its flagship ADHD product, in territories outside of the United States. VYVANSE is approved in the US for the
'/>"/>

SOURCE Shire Plc
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients
2. Shire Enhances its Orphan Drug Pipeline With the Acquisition of a New Clinical Candidate for Metachromatic Leukodystrophy
3. Shire to Present Additional Scientific Data on ADHD Treatment Portfolio at American Psychiatric Association Annual Meeting
4. Shires Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose
5. Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil
6. Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent
7. Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain
8. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
9. Boston Scientific Announces Schedule for European Society of Cardiology Congress 2007
10. European Experts Recommend Pregnant and Nursing Women Take More DHA - Every Day
11. Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...c. 1 CCS Medical, Inc. a leading d...day announced that it has received approval from t...Delaware (the "Court") for its bidding procedures ... of substantially all of its assets. ,, Pursuan...pproved bidding procedures for the sale of substan...
(Date:12/1/2009)...PRNewswire-FirstCall/ -- WebMD Health Corp. (Nasda...on, today announced the honorees of the 2009 WebMD...lth Heroes honor Americans with extraordinary stor... an effort to help others achieve better health. ...prnh/20091201/NY18114 ) ,, "WebMD is honoring ...
(Date:12/1/2009)..., Dec. 1 nContact Surgical, Inc. (...ces for minimally-invasive treatment for heart con...bility clinical trial designed to evaluate the saf...er procedure, the convergent procedure, for the tr...ion (AF). This prospective, feasibility study wil...
Breaking Medicine Technology:CCS Medical Wins Approval from Bankruptcy Court for Its Chapter 11 Asset Sale Bidding Procedures 2WebMD Announces 2009 Health Heroes 2WebMD Announces 2009 Health Heroes 3nContact Announces Initiation of Clinical Trials for the Treatment of Paroxysmal Atrial Fibrillation Utilizing New Convergent Ablation Procedure 2Cobb Pediatric Therapy Services Joins Forces with Travis Consulting LLC to Offer Expanded Services Across the U S 57905 1Cobb Pediatric Therapy Services Joins Forces with Travis Consulting LLC to Offer Expanded Services Across the U S 57905 2Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in Second Line Metastatic Colorectal Cancer 5028 1Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in Second Line Metastatic Colorectal Cancer 5028 2Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in Second Line Metastatic Colorectal Cancer 5028 3Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in Second Line Metastatic Colorectal Cancer 5028 4Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in Second Line Metastatic Colorectal Cancer 5028 5Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in Second Line Metastatic Colorectal Cancer 5028 6Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in Second Line Metastatic Colorectal Cancer 5028 7Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in Second Line Metastatic Colorectal Cancer 5028 8Clinton Global Initiative 3A September 22 25 2009 3A Health Care Access and Quality Improves For Millions in Rwanda and Haiti Due to Innovative Perfo 57899 1Clinton Global Initiative 3A September 22 25 2009 3A Health Care Access and Quality Improves For Millions in Rwanda and Haiti Due to Innovative Perfo 57899 2Clinton Global Initiative 3A September 22 25 2009 3A Health Care Access and Quality Improves For Millions in Rwanda and Haiti Due to Innovative Perfo 57899 3
...d in Third Quarter -, SAN FRANCISCO, March 20 VI...y company focused on the development of,compounds ...nced today that,it has completed patient enrollmen...irst of three Phase 2 trials investigating VIA-229...1 is a potent small molecule drug that targets inf...
... not the Only Way We Suffer - Allerg...N.J. and WHITEHOUSE STATION, N.J., March 20, Indoo...ople in the United States.(1)(2) Yet, according to... survey, allergies are often,disregarded as a nuis...ect.,As a result, allergy sufferers continue to co...
Other Medicine Technology:VIA Pharmaceuticals Completes Enrollment In Phase 2 Carotid Endarterectomy (CEA) Trial 2VIA Pharmaceuticals Completes Enrollment In Phase 2 Carotid Endarterectomy (CEA) Trial 3VIA Pharmaceuticals Completes Enrollment In Phase 2 Carotid Endarterectomy (CEA) Trial 4VIA Pharmaceuticals Completes Enrollment In Phase 2 Carotid Endarterectomy (CEA) Trial 5New Survey Suggests Cultural Ambivalence to Allergies Leaves Many Suffering Needlessly 2New Survey Suggests Cultural Ambivalence to Allergies Leaves Many Suffering Needlessly 3New Survey Suggests Cultural Ambivalence to Allergies Leaves Many Suffering Needlessly 4New Survey Suggests Cultural Ambivalence to Allergies Leaves Many Suffering Needlessly 5New Survey Suggests Cultural Ambivalence to Allergies Leaves Many Suffering Needlessly 6New Survey Suggests Cultural Ambivalence to Allergies Leaves Many Suffering Needlessly 7
(Date:12/1/2009)...re-FirstCall/ -- With employee benefit choices bec...are providing self-service decision-making tools t... to a new survey by Watson Wyatt, a leading global...r these tools believe they lead employees to make ...o the survey, 45 percent of companies offered empl...
(Date:12/1/2009)...wswire-USNewswire/ -- On December 31, 2008, a repo...oners were HIV positive or had confirmed AIDS, the...of Justice Programs, U.S. Department of Justice, a...2 inmates in state and federal prisons had confirm...3 per 10,000 prison inmates were estimated to have...
(Date:12/1/2009)...merica, study finds , , TUESDAY, Dec. 1 ...care unit patients worldwide suffer infections, wh...a new study finds. , Researchers analyzed data ...patients, aged 18 and older, in 1,265 ICUs in 75 c...ere classified as infected and 71 percent were rec...
(Date:12/1/2009)...r Institute researchers and collaborators from the...y have identified immune system markers in the blo...e at high risk for developing lung cancer. The fin...arch , a journal of the American Association for C...to detect lung cancer in its earliest phases, when...
(Date:12/1/2009)...C., Dec. 1 Max Neeman Pharmacy ser...r the years serving the top most pharmaceutical co...y set up in an area of 2000 sq. ft. has now double... of services by Max Neeman, are recognized by the ..., The pharmacy inventory management process is co...
Breaking Medicine News(10 mins):Health News:Employers Plan to Increase Use of Self-Service Decision-Making Technology For Open Enrollment, Watson Wyatt Survey Finds 2Health News:Employers Plan to Increase Use of Self-Service Decision-Making Technology For Open Enrollment, Watson Wyatt Survey Finds 3Health News:Rate of Confirmed AIDS in Prison 2.5 Times the Rate in the U.S. General Population 2Health News:Rate of Confirmed AIDS in Prison 2.5 Times the Rate in the U.S. General Population 3Health News:Half of ICU Patients Suffer From Infections 2Health News:Wistar-led research team discovers genetic pattern that indicates early-stage lung cancer 2Health News:Wistar-led research team discovers genetic pattern that indicates early-stage lung cancer 3
...their rich color from lycopene, a disease-fighting...a special variety of orange-colored tomatoes provi...dies may more readily use. Researchers found ...in participants' blood. “While red tomatoes...
...ledge are great healers and 140 French psychiatris...study this value system. // "The Indian val...dealing with mental health issues and we are here ... to tackle it. India is a huge country and its tra...
...m holes in their eardrums could have better succes... doctors at West Virginia University. // The ... Otolaryngology – Head and Neck Surgery, the offic...study measured success rates of patching eardrum h...
...regnant should opt for ice creams and whole milk i...tudy undertook by Jorge Chavarro and colleagues// .... This study was conducted in the United Stat...ee milk may prove counter productive for women who...
...bsite Netmums, has the outcome that a majority of ... and understandable//, especially when in a hurry ...0 persons interviewed supported the ‘traffic light...each color signifies an amount. For example, red s...
...the Methodist DeBakey Heart Center in Houston show...lesterol by an unprecedented// 70 percent, and has...flammation that can lead to heart disease and stro...for inflammation, in patients treated with 40 mg o...
Other Medicine News:Health News:Unique Tomatoes Tops In Disease-Fighting Antioxidants 2Health News:Unique Tomatoes Tops In Disease-Fighting Antioxidants 3Health News:Inner-ear Volume Study Leads to Higher Surgery Success Rates 2Health News:Mothers Gives ‘thumbs Up’ for Traffic Light Labeli 2Health News:Statin Therapy Cuts Bad Cholesterol Unprecedented 70 Percent 2
...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals...
...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals...
...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals...
...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals...
Medicine Products: